Table 3.
Demographic characteristics of patients in type A and type B PAD.
| Type A PAD (n = 58) | Type B PAD (n = 14) | P value | |
|---|---|---|---|
| Gender | |||
| Male | 34 (58.6%) | 8 (57.1%) | |
| Female | 24 (41.4%) | 6 (42.9%) | 0.920 |
| Age | |||
| <40 | 1 (1.7%) | 0 (0%) | |
| 40 ~ 49 | 5 (8.6%) | 0 (0%) | |
| 50 ~ 59 | 4 (6.9%) | 3 (21.4%) | |
| 60 ~ 69 | 10 (17.2%) | 8 (57.1%) | |
| ≥ 70 | 38 (65.5%) | 3 (21.4%) | 0.005 |
| CBD | |||
| Mean diameter of stones (mm) | 12.4 ± 3.4 (5–22) | 9.5 ± 3.2 (7–15) | 0.007 |
| Mean number of stones | 2.2 ± 1.5 | 1.6 ± 1.3 | 0.147 |
| Mean diameter of CBD (mm) | 13.5 ± 3.4 (7–23) | 10.2 ± 3.5 (8–16) | 0.005 |
| Number | |||
| < 3 | 51 (87.9%) | 7 (50.0%) | |
| ≥ 3 | 7 (12.1%) | 7 (50.0%) | 0.001 |
| Size | |||
| < 1 cm | 34 (58.6%) | 8 (57.1%) | |
| 1 ~ 2 cm | 19 (32.8%) | 6 (42.9%) | |
| ≥ 2 cm | 5 (8.6%) | 0 (0%) | 0.462 |
| Context | |||
| Jaundice | 24 (41.3%) | 5 (35.7%) | 0.698 |
| Abnormal liver function | 17 (29.3%) | 4 (28.6%) | 0.956 |
| Cholangitis | 10 (17.2%) | 2 (14.3%) | 0.790 |
| Biliary pancreatitis | 4 (6.9%) | 1 (7.1%) | 0.974 |
| Aspirin/anticoagulants | 4 (6.9%) | 2 (14.3%) | 0.369 |
| Comorbidity | |||
| CAD | 8 (13.8%) | 2 (14.3%) | 0.962 |
| COPD | 3 (5.2%) | 0 (0%) | 0.385 |